| Hans-Günter Meyer-Thompson | Amphetamine
Psychedelic drug MDMA moves closer to US approval following success in PTSD trial
Psychedelic drug MDMA moves closer to US approval following success in PTSD trial
Long-awaited trial data show drug is effective at treating post-traumatic stress disorder in a diversity of people. (Nature, 14.09.2023)